Donepezil improves cognition in patients with vascular dementia: Results from study 307, a 24-week, randomized, double-blind, placebo-controlled trial

被引：0

作者：

Roman, GC

Pratt, RD

Perdomo, CA

机构：

[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA

[2] Eisai Inc, Teaneck, NJ USA

来源：

NEUROBIOLOGY OF AGING | 2002年 / 23卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

212

引用

页码：S55 / S55

页数：1

共 50 条

[1] Donepezil improves cognitive function in patients with vascular dementia: Results from study 307, a 24-week, randomized, double-blind, placebo-controlled trial
Pratt, RD
Perdomo, CA
NEUROLOGY, 2002, 58 (07) : A161 - A162
[2] Donepezil-treated patients with vascular dementia demonstrate cognitive and global benefits: Results from study 308, a 24-week, randomized, double-blind, placebo-controlled trial
Salloway, S
Pratt, RD
Perdomo, CA
NEUROBIOLOGY OF AGING, 2002, 23 (01) : S57 - S57
[3] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
Rogers, SL
Farlow, MR
Doody, RS
Mohs, R
Friedhoff, LT
Albala, B
Baumel, B
Booker, G
Dexter, J
Farmer, M
Feighner, JP
Ferris, S
Gordon, B
Gorman, DG
Hanna, G
Harrell, LE
Hubbard, R
Kennedy, J
McCarthy, J
Scharre, DW
Schaerf, F
Schneider, L
Seltzer, B
Siegal, A
Stark, SR
Strauss, A
Walshe, TM
NEUROLOGY, 1998, 50 (01) : 136 - 145
[4] Donepezil treatment of severe Alzheimer's disease: Results from a 24-week, multinational, randomized, double-blind, placebo-controlled trial
Black, S.
Li, H.
McRae, T.
Richardson, S.
EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 69 - 69
[5] Treatment of severe Alzheimer's disease with donepezil: Results from a 24-week, multinational, randomized, double-blind, placebo-controlled trial
Black, S
Li, HL
McRae, T
Richardson, S
NEUROLOGY, 2006, 66 (05) : A347 - A347
[6] Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: Results from a 24-week, double-blind, placebo-controlled, Randomized trial
Homma, Akira
Imai, Yukimichi
Tago, Hisao
Asada, Takashi
Shigeta, Masahiro
Iwamoto, Toshihiko
Takita, Masashi
Arimoto, Itaru
Koma, Hiroshi
Ohbayashi, Toshio
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (05) : 399 - 407
[7] A comparison of the effects of donepezil in patients with probable and possible vascular dementia: A combined analysis of two 24-week, randomized, double-blind, placebo-controlled trials
Perdomo, CA
Pratt, RD
NEUROLOGY, 2002, 58 (07) : A382 - A382
[8] A comparison of the cognitive benefits of donepezil in patients with cortical and subcortical vascular dementia: A subanalysis of two 24-week, randomized, double-blind, placebo-controlled trials
Passmore, AP
Pratt, RD
Perdomo, CA
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 229 : 303 - 304
[9] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease - Pilot Study
Prasher, VP
Huxley, A
Haque, MS
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 17 (03) : 270 - 278
[10] Efficacy and tolerability of donepezil in vascular dementia -: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial
Black, S
Román, GC
Geldmacher, DS
Salloway, S
Hecker, J
Burns, A
Perdomo, C
Kumar, D
Pratt, R
STROKE, 2003, 34 (10) : 2323 - 2330

← 1 2 3 4 5 →